Advanced search
Publication Cover
Climacteric Volume 26, 2023 - Issue 4: Special Issue: Genitourinary syndrome of menopause
Submit an article Journal homepage
1,478
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy and safety of ultra-low-dose estradiol and norethisterone in postmenopausal Brazilian women

R. Bonassi Machadoa Department of Gynecology and Obstetrics, Jundiai School of Medicine, Jundiai, BrazilCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9361-0905View further author information
ORCID Icon,
L. de Melo Pompeib Department of Gynecology and Obstetrics, ABC School of Medicine, Santo Andre, BrazilORCID Iconhttps://orcid.org/0000-0001-7084-037XView further author information
ORCID Icon,
E. A. P. Nahasc Department of Gynecology and Obstetrics, Botucatu School of Medicine UNESP – Sao Paulo State University, Botucatu, BrazilORCID Iconhttps://orcid.org/0000-0002-0803-8535View further author information
ORCID Icon,
J. Nahas-Netoc Department of Gynecology and Obstetrics, Botucatu School of Medicine UNESP – Sao Paulo State University, Botucatu, BrazilORCID Iconhttps://orcid.org/0000-0002-4662-5378View further author information
ORCID Icon,
L. da Costa-Paivad Department of Obstetrics and Gynecology, State University of Campinas, Campinas, BrazilORCID Iconhttps://orcid.org/0000-0002-9088-6700View further author information
ORCID Icon,
S. Y. O. Del Debbioe Paulista Center for Clinical Research, CEPIC, Sao Paulo, BrazilORCID Iconhttps://orcid.org/0000-0003-2597-1877View further author information
ORCID Icon,
M. Badalottif Department of Gynecology and Obstetrics, PUC-RS, Porto Alegre, BrazilORCID Iconhttps://orcid.org/0000-0003-0770-8311View further author information
ORCID Icon,
M. C. O. Wenderg Department of Obstetrics and Gynecology, School of Medicine, UFRGS – Federal University of Rio Grande do Sul, Porto Alegre, BrazilORCID Iconhttps://orcid.org/0000-0001-9085-4605View further author information
ORCID Icon &
A. M. Cruzh Department of Clinical Research, Libbs Farmacêutica Ltda, Sao Paulo, BrazilORCID Iconhttps://orcid.org/0000-0001-6655-5875View further author information
ORCID Icon show all
Pages 401-407 | Received 05 Aug 2022, Accepted 04 Mar 2023, Published online: 28 Mar 2023

References

  • Baber RJ, Panay N, Fenton A. IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–150.
  • de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised global consensus statement on menopausal hormone therapy. Maturitas. 2016;91:153–155.
  • The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24(7):728–753.
  • Pompei L, Machado R, Wender M, et al. Consenso Brasileiro de Terapêutica Hormonal da Menopausa – Associação Brasileira de Climatério (SOBRAC). Leitura Médica. 2018.
  • Santoro N, Epperson CN, Mathews SB. Menopausal symptoms and their management. Endocrinol Metab Clin North Am. 2015;44(3):497–515.
  • Maclennan AH, Broadbent JL, Lester S, et al. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;18(4):CD002978.
  • Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA. 2004;291(13):1610–1620.
  • Ettinger B. Rationale for use of lower estrogen doses for postmenopausal hormone therapy. Maturitas. 2007;57(1):81–84.
  • Langer RD. Efficacy, safety, and tolerability of low-dose hormone therapy in managing menopausal symptoms. J Am Board Fam Med. 2009;22(5):563–573.
  • Gambacciani M, Biglia N, Cagnacci A, et al. Menopause and hormone replacement therapy: the 2017 recommendations of the Italian menopause society. Minerva Ginecol. 2018;70(1):27–34.
  • Notelovitz M, Lenihan JP, McDermott M, et al. Initial 17beta-estradiol dose for treating vasomotor symptoms. Obstet Gynecol. 2000;95(5):726–731.
  • Johansen OE, Qvigstad E. Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg. Adv Therapy. 2008;25(6):525–551.
  • Stute P, Becker HG, Bitzer J, et al. Ultra-low dose – new approaches in menopausal hormone therapy. Climacteric. 2015;18(2):182–186.
  • Panay N, Ylikorkala O, Archer DF, et al. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. Climacteric. 2007;10(2):120–131.
  • Sturdee DW, Archer DF, Rakov V, et al. Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women. Climacteric. 2008;11(1):63–73.
  • Mattsson L, Ipsen HE, Granqvist CJ, et al. Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52 weeks of therapy. Climacteric. 2015;18(3):419–425.
  • Notelovitz M, Mattox JH. Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17beta-estradiol. Menopause. 2000;7(5):310–317.
  • Costa-Paiva L, O Wender MC, Machado RB, et al. Effects of ultra-low dose hormone therapy on biochemical bone turnover markers in postmenopausal women: a randomized, placebo-controlled, double-blind trial. Post Reprod Health. 2022;28(3):149–157.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.